BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 29056364)

  • 1. Apolipoprotein E as a novel therapeutic neuroprotection target after traumatic spinal cord injury.
    Cheng X; Zheng Y; Bu P; Qi X; Fan C; Li F; Kim DH; Cao Q
    Exp Neurol; 2018 Jan; 299(Pt A):97-108. PubMed ID: 29056364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ApoE mimetic ameliorates motor deficit and tissue damage in rat spinal cord injury.
    Wang R; Hong J; Lu M; Neil JE; Vitek MP; Liu X; Warner DS; Li F; Sheng H
    J Neurosci Res; 2014 Jul; 92(7):884-92. PubMed ID: 24633884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Agonist of the Protective Factor SIRT1 Improves Functional Recovery and Promotes Neuronal Survival by Attenuating Inflammation after Spinal Cord Injury.
    Chen H; Ji H; Zhang M; Liu Z; Lao L; Deng C; Chen J; Zhong G
    J Neurosci; 2017 Mar; 37(11):2916-2930. PubMed ID: 28193684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-energy extracorporeal shock wave therapy for promotion of vascular endothelial growth factor expression and angiogenesis and improvement of locomotor and sensory functions after spinal cord injury.
    Yahata K; Kanno H; Ozawa H; Yamaya S; Tateda S; Ito K; Shimokawa H; Itoi E
    J Neurosurg Spine; 2016 Dec; 25(6):745-755. PubMed ID: 27367940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA-approved 5-HT
    Simmons EC; Scholpa NE; Schnellmann RG
    Exp Neurol; 2021 Jul; 341():113720. PubMed ID: 33848513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maresin 1 Promotes Inflammatory Resolution, Neuroprotection, and Functional Neurological Recovery After Spinal Cord Injury.
    Francos-Quijorna I; Santos-Nogueira E; Gronert K; Sullivan AB; Kopp MA; Brommer B; David S; Schwab JM; López-Vales R
    J Neurosci; 2017 Nov; 37(48):11731-11743. PubMed ID: 29109234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-hydroxytryptamine 1F Receptor Agonist Induces Mitochondrial Biogenesis and Promotes Recovery from Spinal Cord Injury.
    Simmons EC; Scholpa NE; Cleveland KH; Schnellmann RG
    J Pharmacol Exp Ther; 2020 Feb; 372(2):216-223. PubMed ID: 31776207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aescin reduces oxidative stress and provides neuroprotection in experimental traumatic spinal cord injury.
    Cheng P; Kuang F; Ju G
    Free Radic Biol Med; 2016 Oct; 99():405-417. PubMed ID: 27596954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of low dose estrogen attenuates persistent inflammation, promotes angiogenesis, and improves locomotor function following chronic spinal cord injury in rats.
    Samantaray S; Das A; Matzelle DC; Yu SP; Wei L; Varma A; Ray SK; Banik NL
    J Neurochem; 2016 May; 137(4):604-17. PubMed ID: 26998684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FTY720 improves functional recovery after spinal cord injury by primarily nonimmunomodulatory mechanisms.
    Norimatsu Y; Ohmori T; Kimura A; Madoiwa S; Mimuro J; Seichi A; Yatomi Y; Hoshino Y; Sakata Y
    Am J Pathol; 2012 Apr; 180(4):1625-35. PubMed ID: 22417787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of p21-Activated Kinase 1 by IPA-3 Promotes Locomotor Recovery After Spinal Cord Injury in Mice.
    Ji X; Zhang Y; Zhang L; Chen H; Peng Y; Tang P
    Spine (Phila Pa 1976); 2016 Jun; 41(11):919-925. PubMed ID: 26863260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TLR4 Deficiency Impairs Oligodendrocyte Formation in the Injured Spinal Cord.
    Church JS; Kigerl KA; Lerch JK; Popovich PG; McTigue DM
    J Neurosci; 2016 Jun; 36(23):6352-64. PubMed ID: 27277810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nafamostat mesilate attenuates inflammation and apoptosis and promotes locomotor recovery after spinal cord injury.
    Duan HQ; Wu QL; Yao X; Fan BY; Shi HY; Zhao CX; Zhang Y; Li B; Sun C; Kong XH; Zhou XF; Feng SQ
    CNS Neurosci Ther; 2018 May; 24(5):429-438. PubMed ID: 29352519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of Shh/Gli1 signaling in the permeability of blood-spinal cord barrier and locomotion recovery after spinal cord contusion.
    Yue Y; Zhao J; Li X; Zhang L; Su Y; Fan H
    Neurosci Lett; 2020 May; 728():134947. PubMed ID: 32276104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine attenuates morphological deficits in a contusion model of spinal cord injury.
    Ravikumar R; Fugaccia I; Scheff SW; Geddes JW; Srinivasan C; Toborek M
    J Neurotrauma; 2005 Feb; 22(2):240-51. PubMed ID: 15716630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloperoxidase exacerbates secondary injury by generating highly reactive oxygen species and mediating neutrophil recruitment in experimental spinal cord injury.
    Kubota K; Saiwai H; Kumamaru H; Maeda T; Ohkawa Y; Aratani Y; Nagano T; Iwamoto Y; Okada S
    Spine (Phila Pa 1976); 2012 Jul; 37(16):1363-9. PubMed ID: 22322369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolvin D3 Promotes Inflammatory Resolution, Neuroprotection, and Functional Recovery After Spinal Cord Injury.
    Kim J; Joshi HP; Sheen SH; Kim KT; Kyung JW; Choi H; Kim YW; Kwon SY; Roh EJ; Choi UY; Sohn S; Kim YH; Park CK; Kumar H; Han IB
    Mol Neurobiol; 2021 Jan; 58(1):424-438. PubMed ID: 32964315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of thymosin β4 on spinal cord injury in the rat.
    Cheng P; Kuang F; Zhang H; Ju G; Wang J
    Neuropharmacology; 2014 Oct; 85():408-16. PubMed ID: 24937047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute administration of ucf-101 ameliorates the locomotor impairments induced by a traumatic spinal cord injury.
    Reigada D; Nieto-Díaz M; Navarro-Ruiz R; Caballero-López MJ; Del Águila A; Muñoz-Galdeano T; Maza RM
    Neuroscience; 2015 Aug; 300():404-17. PubMed ID: 26004679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking Autophagy in Oligodendrocytes Limits Functional Recovery after Spinal Cord Injury.
    Saraswat Ohri S; Bankston AN; Mullins SA; Liu Y; Andres KR; Beare JE; Howard RM; Burke DA; Riegler AS; Smith AE; Hetman M; Whittemore SR
    J Neurosci; 2018 Jun; 38(26):5900-5912. PubMed ID: 29793971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.